Comparison of Ticagrelor and Clopidogrel in Patients with Acute Coronary Syndrome at High Bleeding o...
Comparison of Ticagrelor and Clopidogrel in Patients with Acute Coronary Syndrome at High Bleeding or Ischemic Risk
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Current guidelines recommend individualizing the choice and duration of P2Y12 inhibitor therapy based on the trade-off between bleeding and ischemic risk. However, whether a potent P2Y12 inhibitor (ticagrelor) or a less potent one (clopidogrel) is more appropriate in patients with acute coronary syndrome (ACS) in the setting of high bleeding or isc...
Alternative Titles
Full title
Comparison of Ticagrelor and Clopidogrel in Patients with Acute Coronary Syndrome at High Bleeding or Ischemic Risk
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2881710622
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2881710622
Other Identifiers
ISSN
0002-9149,1879-1913
E-ISSN
1879-1913
DOI
10.1016/j.amjcard.2023.10.046
